s6y
Company name or ticker
Search
Obsidian Therapeutics, Inc.
3
Reisenauer Mark L: Initial statement of beneficial ownership of securities
Filed
Friday, November 13, 2026
Period
Nov 10, 2026
Accession number
0001104659-26-127194
Documents
OWNERSHIP DOCUMENT
3
EXHIBIT 24
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header